Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 12, 2012 - Issue 9
Submit an article Journal homepage
127
Views
7
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Can botulinum toxin improve mood in depressed patients?

Changsu Han Department of Psychiatry, College of Medicine, Korea University, Seoul, South Korea; Department of Psychiatry, College of Medicine, Korea University, Seoul, South Korea
,
Geun-Young Park Department of Rehabilitation Medicine, The Catholic University of Korea College of Medicine, Seoul, South Korea
,
Sheng-Min Wang Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea
,
Seung-Yeop Lee Medical Sciences, Graduate School, The Catholic University of Korea, Seoul, South Korea; Medical Sciences, Graduate School, The Catholic University of Korea, Seoul, South Korea
,
Soo-Jung Lee Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea
,
Won-Myong Bahk Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea
&
Chi-Un Pae Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Department of Psychiatry, Bucheon St Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, Kyeonggi-Do 420–717, South Korea. [email protected]; Department of Psychiatry, Bucheon St Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, Kyeonggi-Do 420–717, South Korea. [email protected]
 show all
Pages 1049-1051 | Published online: 09 Jan 2014

References

  • Pae CU, Forbes A, Patkar AA. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs, 25(2), 109–127 (2011).
  • Pae CU, Serretti A, Patkar AA, Masand PS. Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. CNS Drugs, 22(5), 367–388 (2008).
  • Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9(6), 449–459 (2007).
  • Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr. Serv. 60(11), 1439–1445 (2009).
  • Lin EH, Von Korff M, Ludman EJ et al. Enhancing adherence to prevent depression relapse in primary care. Gen. Hosp. Psychiatry 25(5), 303–310 (2003).
  • Finzi E, Wasserman E. Treatment of depression with botulinum toxin A: a case series. Dermatol. Surg. 32(5), 645–649; discussion 649 (2006).
  • Wollmer MA, de Boer C, Kalak N et al. Facing depression with botulinum toxin: a randomized controlled trial. J. Psychiatr. Res. 46(5), 574–581 (2012).
  • Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 23, 56–62 (1960).
  • Honeck P, Weiss C, Sterry W, Rzany B; Gladys study group. Reproducibility of a four-point clinical severity score for glabellar frown lines. Br. J. Dermatol. 149(2), 306–310 (2003).
  • Martin JL, Martín-Sánchez E. Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur. Psychiatry 27(3), 147–155 (2012).
  • Fitzgerald PB, Daskalakis ZJ. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev. Med. Devices 8(1), 85–95 (2011).
  • Flynn TC. Botulinum toxin: examining duration of effect in facial aesthetic applications. Am. J. Clin. Dermatol. 11(3), 183–199 (2010).
  • Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J. Clin. Psychiatry 71(10), 1259–1272 (2010).
  • Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J. Clin. Psychopharmacol. 29(3), 259–266 (2009).
  • Heckmann M, Teichmann B, Schröder U, Sprengelmeyer R, Ceballos-Baumann AO. Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear. J. Am. Acad. Dermatol. 49(2), 213–216 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.